Skip to main content
Premium Trial:

Request an Annual Quote

Getting to the Clinic

Technology Review takes a look at Nanosphere's Verigene, a tool that uses both microfluidics and nanotechnology to screen DNA from a blood sample. "We believe the benefit of our system is that this simple cartridge format could be run in any hospital, even a doctor's office," the company's chief executive says. "We're moving complex testing to the point of patient care." Instead of testing taking days, Nanosphere is developing their product to do so in an hour or two.

"If it works, this could be a convenient way for physicians and coagulation clinics to incorporate pharmacogenomic information into warfarin dosing," adds Karen Weck, who directs UNC-Chapel Hill's molecular genetics laboratory.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.